Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Y Omori
Institutions:
University of Oxford,
MRC Population Health Research Unit
Observed institutions:
University of Oxford,
MRC Population Health Research Unit
OpenAlex ID:
A5113940702
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
2023
·
PK Judge
, N Staplin
, et al.
·
The Lancet Diabetes & Endocrinology
·
141
PDF
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
2023
·
N Staplin
, R Haynes
, et al.
·
The Lancet Diabetes & Endocrinology
·
118
PDF
Accumulation of phosphatydilcholine-hydroperoxide in dialysis patients with diabetic nephropathy.
1995
·
T Sanaka
, C Takahashi
, et al.
·
PubMed
·
15
[Symposium: kidney diseases from the standpoint of clinical diagnosis. Simplified kidney function tests].
1967
·
Y Omori
·
PubMed
Show more works
View as search
Works count:
4
Citation count:
274
H-index:
3
I10-index:
3
Year
Topic
Type
